Accordingly, we found that the enhanced MTX anti-tumor responses of Cdk2-/- cancer cells over WT cells were abolish with WT Cdk2 but not Cdk2T160A reconstitution (Figures 5A–D). The gene discussed is CDK2; the disease is cancer.